Silke Baasner
Impact in
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents
- Organic Chemistry top 10%
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Catalytic C–H Functionalization Methods
- Click Chemistry and Applications
- Quinazolinone synthesis and applications
Papers in
-
- Synthesis and biological activity 9
- Synthesis and Biological Evaluation 3
-
- Cancer therapeutics and mechanisms 4
- Co-authors
- E Günther (9 shared papers)Thomas Beckers (3 shared papers)Péter Schmidt (7 shared papers)Matthias Gerlach (7 shared papers)Klaus Müller (5 shared papers)Eberhard Unger (5 shared papers)Helge Prinz (5 shared papers)Konrad J. Böhm (5 shared papers)
- Journals
- Journal of Medicinal Chemistry (5 papers)Bioorganic & Medicinal Chemistry (2 papers)European Journal of Medicinal Chemistry (1 paper)Journal of Enzyme Inhibition and Medicinal Chemistry (1 paper)Critical Care (1 paper)
- Partner nations
- GermanyNetherlandsFrance
In The Last Decade
Silke Baasner
15 papers receiving 404 citations
Peers
Comparison fields: 5 of 66
- Toxicology 34
- Organic Chemistry 252
- Critical Care and Intensive Care Medicine 15
- Oncology 67
- Pharmacology 37
Countries citing papers authored by Silke Baasner
This map shows the geographic impact of Silke Baasner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silke Baasner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silke Baasner more than expected).
Fields of papers citing papers by Silke Baasner
This network shows the impact of papers produced by Silke Baasner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silke Baasner. The network helps show where Silke Baasner may publish in the future.
Co-authors
The 25 scholars most cited alongside Silke Baasner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 91 | |
| 2 | 2002 | 68 | |
| 3 | 2007 | 45 | |
| 4 | 2017 | 30 | |
| 5 | Reversible tumorigenesis in mice by conditional expression of the HER2/c-erbB2 receptor tyrosine kinase. | 1996 | 26 |
| 6 | 2009 | 26 | |
| 7 | 2010 | 22 | |
| 8 | 2006 | 22 | |
| 9 | 2009 | 20 | |
| 10 | 2013 | 20 | |
| 11 | 2011 | 17 | |
| 12 | 2016 | 17 | |
| 13 | 2004 | 5 | |
| 14 | 2008 | 2 | |
| 15 | 4-Substituted-piperazin-1-yl-carbonyl-pyrazol derivatives: A new class of highly potent cytotoxic compounds with inhibitory effects on tubulin polymerization | 2004 | 1 |
About Silke Baasner
Silke Baasner is a scholar working on Organic Chemistry, Molecular Biology, Pharmacology, Oncology and Toxicology, having authored 15 papers that have together received 412 indexed citations. Recurring topics across this work include Synthesis and biological activity (9 papers), Cancer therapeutics and mechanisms (4 papers), Synthesis and Biological Evaluation (3 papers), Bioactive Compounds and Antitumor Agents (3 papers), Microbial Natural Products and Biosynthesis (2 papers), Synthesis of Organic Compounds (2 papers), Sepsis Diagnosis and Treatment (2 papers) and Fungal Plant Pathogen Control (1 paper). The work is most often cited by research in Toxicology (34 citations), Organic Chemistry (252 citations), Critical Care and Intensive Care Medicine (15 citations), Oncology (67 citations) and Pharmacology (37 citations). Silke Baasner has collaborated with scholars based in Germany, Netherlands and France. Frequent co-authors include E Günther, Thomas Beckers, Péter Schmidt, Matthias Gerlach, Klaus Müller, Eberhard Unger, Helge Prinz, Konrad J. Böhm, Herwig Pongratz and Frank‐D. Böhmer. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, European Journal of Medicinal Chemistry, Journal of Enzyme Inhibition and Medicinal Chemistry and Critical Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.